City of Hope

www.cityofhope.org

 

Lymphoma
11:41

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Glofitamab Monotherapy in Patients With Heavily Pretreated R/R MCL"

FEATURING Tycel Phillips
  • 61 views
  • June 25, 2024
10:57

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Mosunetuzumab + Polatuzumab Vedotin in Pts With R/R LBCL"

FEATURING Elizabeth Budde
  • 132 views
  • December 20, 2023
10:21

SOHO 2023 Eleventh Annual Meeting

SOHO 2023 Next Questions: HL

FEATURING Alex Herrera
  • 126 views
  • October 19, 2023
19:32

SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Tailoring Therapy for PTCL

FEATURING Jasmine Zain
  • 78 views
  • October 12, 2023
  • 1
10:33

SOHO 2023 Eleventh Annual Meeting

SOHO 2023: A Multidisciplinary Approach to the Management of Mycosis Fungoides

FEATURING Christiane Querfeld
  • 71 views
  • October 12, 2023
06:21

City of Hope

Cardiac Safety of Zanubrutinib vs. Other BTKis in CLL

FEATURING Alexey Danilov
  • 678 views
  • June 23, 2023
  • 3
12:24

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Real-World Outcomes of Brexu-Cel for R/R MCL - A CIBMTR Subgroup Analysis by Prior Treatment"

FEATURING Swetha Kambhampati
  • 63 views
  • June 22, 2023
06:50

ecancer

ASCO® 2023 Insights: "S1826 Study Summary - Nivolumab-AVD vs. Brentuximab Vedotin-AVD in Pts With Advanced Stage HL"

FEATURING Alex Herrera
  • 73 views
  • June 14, 2023
06:16

City of Hope

Current Perspective on CAR-T Therapy in Mantle Cell Lymphoma

FEATURING Alexey Danilov
  • 158 views
  • January 11, 2023
  • 1
07:48

City of Hope

Tolerability of BTKi in R/R MCL

FEATURING Tycel Phillips
  • 200 views
  • October 12, 2022
  • 1
18:31

City of Hope

Novel Treatment Options for DLBCL - Overview of Targeted Therapies and Related Clinical Trials

FEATURING Jasmine Zain
  • 391 views
  • May 16, 2018
  • 2
30:08

City of Hope

Advances in Therapy in Cutaneous T Cell Lymphoma

FEATURING Christiane Querfeld
  • 151 views
  • November 21, 2018